177 related articles for article (PubMed ID: 25628221)
1. CSF-1-activated macrophages are target-directed and essential mediators of Schwann cell dedifferentiation and dysfunction in Cx32-deficient mice.
Groh J; Klein I; Hollmann C; Wettmarshausen J; Klein D; Martini R
Glia; 2015 Jun; 63(6):977-86. PubMed ID: 25628221
[TBL] [Abstract][Full Text] [Related]
2. Cell-Surface and Secreted Isoforms of CSF-1 Exert Opposing Roles in Macrophage-Mediated Neural Damage in Cx32-Deficient Mice.
Groh J; Basu R; Stanley ER; Martini R
J Neurosci; 2016 Feb; 36(6):1890-901. PubMed ID: 26865613
[TBL] [Abstract][Full Text] [Related]
3. Altered gene expression in Schwann cells of connexin32 knockout animals.
Nicholson SM; Gomès D; de Néchaud B; Bruzzone R
J Neurosci Res; 2001 Oct; 66(1):23-36. PubMed ID: 11598999
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X.
Groh J; Heinl K; Kohl B; Wessig C; Greeske J; Fischer S; Martini R
Hum Mol Genet; 2010 Sep; 19(18):3530-43. PubMed ID: 20591826
[TBL] [Abstract][Full Text] [Related]
5. Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease.
Sargiannidou I; Kagiava A; Bashiardes S; Richter J; Christodoulou C; Scherer SS; Kleopa KA
Ann Neurol; 2015 Aug; 78(2):303-16. PubMed ID: 26010264
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling studies in regenerating nerves in a mouse model for CMT1X: uninjured Cx32-knockout peripheral nerves display expression profile of injured wild type nerves.
Freidin M; Asche-Godin S; Abrams CK
Exp Neurol; 2015 Jan; 263():339-49. PubMed ID: 25447941
[TBL] [Abstract][Full Text] [Related]
7. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice.
Scherer SS; Xu YT; Messing A; Willecke K; Fischbeck KH; Jeng LJ
J Neurosci; 2005 Feb; 25(6):1550-9. PubMed ID: 15703409
[TBL] [Abstract][Full Text] [Related]
8. Nonuniform molecular features of myelinating Schwann cells in models for CMT1: distinct disease patterns are associated with NCAM and c-Jun upregulation.
Klein D; Groh J; Wettmarshausen J; Martini R
Glia; 2014 May; 62(5):736-50. PubMed ID: 24526449
[TBL] [Abstract][Full Text] [Related]
9. Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X.
Groh J; Weis J; Zieger H; Stanley ER; Heuer H; Martini R
Brain; 2012 Jan; 135(Pt 1):88-104. PubMed ID: 22094537
[TBL] [Abstract][Full Text] [Related]
10. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
[TBL] [Abstract][Full Text] [Related]
11. Role of immune cells in animal models for inherited neuropathies: facts and visions.
Mäurer M; Kobsar I; Berghoff M; Schmid CD; Carenini S; Martini R
J Anat; 2002 Apr; 200(4):405-14. PubMed ID: 12090406
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal gene therapy in mouse models expressing CMT1X mutations.
Kagiava A; Karaiskos C; Richter J; Tryfonos C; Lapathitis G; Sargiannidou I; Christodoulou C; Kleopa KA
Hum Mol Genet; 2018 Apr; 27(8):1460-1473. PubMed ID: 29462293
[TBL] [Abstract][Full Text] [Related]
13. Accelerated demyelination of peripheral nerves in mice deficient in connexin 32 and protein zero.
Neuberg DH; Carenini S; Schachner M; Martini R; Suter U
J Neurosci Res; 1998 Sep; 53(5):542-50. PubMed ID: 9726425
[TBL] [Abstract][Full Text] [Related]
14. The effects of a dominant connexin32 mutant in myelinating Schwann cells.
Jeng LJ; Balice-Gordon RJ; Messing A; Fischbeck KH; Scherer SS
Mol Cell Neurosci; 2006 Jul; 32(3):283-98. PubMed ID: 16790356
[TBL] [Abstract][Full Text] [Related]
15. Golgi-retained Cx32 mutants interfere with gene addition therapy for CMT1X.
Kyriakoudi S; Sargiannidou I; Kagiava A; Olympiou M; Kleopa KA
Hum Mol Genet; 2017 May; 26(9):1622-1633. PubMed ID: 28334782
[TBL] [Abstract][Full Text] [Related]
16. Connexins, gap junctions and peripheral neuropathy.
Kleopa KA; Sargiannidou I
Neurosci Lett; 2015 Jun; 596():27-32. PubMed ID: 25449862
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of X-linked Charcot-Marie-Tooth disease.
Kleopa KA; Scherer SS
Neuromolecular Med; 2006; 8(1-2):107-22. PubMed ID: 16775370
[TBL] [Abstract][Full Text] [Related]
18. Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1.
Kobsar I; Berghoff M; Samsam M; Wessig C; Mäurer M; Toyka KV; Martini R
Brain; 2003 Apr; 126(Pt 4):804-13. PubMed ID: 12615640
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-related demyelination in peripheral nerves of mice deficient in the gap junction protein connexin 32.
Kobsar I; Mäurer M; Ott T; Martini R
Neurosci Lett; 2002 Mar; 320(1-2):17-20. PubMed ID: 11849753
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32.
Abrams CK; Freidin M; Bukauskas F; Dobrenis K; Bargiello TA; Verselis VK; Bennett MV; Chen L; Sahenk Z
J Neurosci; 2003 Nov; 23(33):10548-58. PubMed ID: 14627639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
